MedTrace Logo

Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients

NCT05080543 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2021-10-15

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of combining HSA 20% and terlipressin on the microcirculation in patients with septic shock using the following;-

* Microcirculation recruitment by Cytocam-IDF.
* Cardiac output by LiDCOrapid.
* Measuring serum lactate level.

Conditions

  • Septic Shock

Interventions

DRUG

Albumin 20% and terlipressin

Evaluation the effect of adding 20% HSA and terlipressin on microvascular flow index (MFI), flow heterogeneity index, total vessel density (TVD), and perfused vessel density (PVD) in comparison to the standard care in patient with septic shock.

Sponsors & Collaborators

  • Amany Mousa Salama Muhammed

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-31
Primary Completion
2022-09-30
Completion
2022-10-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05080543 on ClinicalTrials.gov